The aim of this line of action is to obtain neutralising antibodies against SARS-CoV-2, using the technology of generating single domain antibodies with a human VH region and a camelid VHH domain (nanobodies) in bacteria, starting from available nanobody libraries, libraries that are being generated by dromedary immunisation with SARS-CoV-2 antigens, human antibody collections, or by synthesis and mutagenesis of neutralising antibodies.

Principal Investigators: Luis Ángel Fernández, José María Casasnovas, Víctor de Lorenzo

COVID-19 Project. Centro Nacional de Biotecnología (CNB)-CSIC